NCT03194633View on ClinicalTrials.gov

Effectiveness and Tolerability of Long-Acting Nifedipine Gastrointestinal Therapeutic System in Chronic Kidney Disease With Uncontrolled Hypertension Patients, a Prospective, Multicenter, Observational Study

CompletedOBSERVATIONAL
Enrollment

871

Participants

Timeline

Start Date

July 10, 2017

Primary Completion Date

May 14, 2020

Study Completion Date

August 28, 2020

Conditions
Hypertension
Interventions
DRUG

Nifedipine controlled-release tablets(Nifedipine GITS, ADALAT, BAYA1040)

Nifedipine GITS 60 mg (once per day)

Trial Locations (1)

Unknown

Many Locations, Multiple Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY